Therapeutics

Tools

Back to the Top
Search By Attributes

Search Results

Name Synonyms FDA Status Company Target Type Therapy Type Condition Approved
For
BAN2401 2 Eisai Co., Ltd. APP and Amyloid-Related Immunotherapy (passive) Alzheimer's Disease
Bapineuzumab AAB-001 Discontinued Janssen, Pfizer APP and Amyloid-Related Immunotherapy (passive) Alzheimer's Disease
BIIB037 1 Biogen Idec APP and Amyloid-Related Immunotherapy (passive) Alzheimer's Disease
Crenezumab MABT5102A , RG7412 2 Genentech APP and Amyloid-Related Immunotherapy (passive) Alzheimer's Disease None
Gammagard™ Intravenous Immunoglobulin, IVIg Discontinued Baxter Healthcare APP and Amyloid-Related, Inflammation Immunotherapy (passive) Alzheimer's Disease Immunodeficiency conditions
Gamunex Intravenous Immunoglobulin, Human Albumin Combined With Flebogamma 2/3 Grifols Biologicals Inc. APP and Amyloid-Related, Inflammation Immunotherapy (passive) Alzheimer's Disease Immunodeficiency, chronic inflammatory demyelinating neuropathy
Gantenerumab RO4909832, RG1450 3 Chugai Pharmaceutical Co., Ltd., Hoffmann-La Roche APP and Amyloid-Related Immunotherapy (passive) Alzheimer's Disease
Octagam® Intravenous Immunoglobulin, NewGam 2, 2 Octapharma APP and Amyloid-Related, Inflammation Immunotherapy (passive) Alzheimer's Disease, Mild Cognitive Impairment
Ponezumab PF-04360365 Discontinued, 2 Pfizer APP and Amyloid-Related Immunotherapy (passive) Alzheimer's Disease, Cerebral Amyloid Angiopathy None
SAR228810 1 Sanofi APP and Amyloid-Related Immunotherapy (passive) Alzheimer's Disease
Solanezumab LY2062430 3 Eli Lilly & Co. APP and Amyloid-Related Immunotherapy (passive) Alzheimer's Disease None